Portfolio company
Vida Therapeutics Inc.
Lead
About the company
viDA Therapeutics is advancing first-in-class drugs based on inhibitors of the extracellular serine protease, Granzyme B, to treat autoimmune and chronic inflammatory diseases. The company is focused on advancing their lead candidate into the clinic.